Goldman Sachs’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.6M Buy
561,800
+119,068
+27% +$3.73M ﹤0.01% 1858
2025
Q1
$14.9M Buy
442,732
+32,486
+8% +$1.09M ﹤0.01% 1923
2024
Q4
$16.1M Sell
410,246
-49,379
-11% -$1.94M ﹤0.01% 1959
2024
Q3
$18.1M Buy
459,625
+95,452
+26% +$3.76M ﹤0.01% 1809
2024
Q2
$14.2M Buy
364,173
+64,399
+21% +$2.51M ﹤0.01% 1827
2024
Q1
$12.9M Sell
299,774
-76,528
-20% -$3.29M ﹤0.01% 1865
2023
Q4
$17.3M Buy
376,302
+120,934
+47% +$5.57M ﹤0.01% 1673
2023
Q3
$8.72M Sell
255,368
-19,712
-7% -$673K ﹤0.01% 2083
2023
Q2
$10.6M Sell
275,080
-10,343
-4% -$398K ﹤0.01% 1998
2023
Q1
$10.2M Buy
285,423
+1,882
+0.7% +$67.4K ﹤0.01% 2000
2022
Q4
$11.2M Sell
283,541
-181,724
-39% -$7.17M ﹤0.01% 2046
2022
Q3
$16.8M Buy
465,265
+168,951
+57% +$6.1M ﹤0.01% 1731
2022
Q2
$9.01M Sell
296,314
-428,023
-59% -$13M ﹤0.01% 2217
2022
Q1
$22.1M Buy
724,337
+552,943
+323% +$16.9M ﹤0.01% 1650
2021
Q4
$5.35M Buy
171,394
+75,409
+79% +$2.36M ﹤0.01% 2745
2021
Q3
$1.47M Sell
95,985
-56,233
-37% -$859K ﹤0.01% 3718
2021
Q2
$2.83M Buy
152,218
+16,999
+13% +$316K ﹤0.01% 3228
2021
Q1
$2.42M Sell
135,219
-2,742
-2% -$49.1K ﹤0.01% 3213
2020
Q4
$2.12M Buy
137,961
+75,995
+123% +$1.17M ﹤0.01% 3035
2020
Q3
$686K Buy
61,966
+32,694
+112% +$362K ﹤0.01% 3508
2020
Q2
$367K Buy
+29,272
New +$367K ﹤0.01% 3736
2020
Q1
Sell
-12,937
Closed -$170K 4574
2019
Q4
$170K Buy
12,937
+2,408
+23% +$31.6K ﹤0.01% 4024
2019
Q3
$95K Buy
+10,529
New +$95K ﹤0.01% 4055
2019
Q2
Sell
-12,246
Closed -$124K 4299
2019
Q1
$124K Sell
12,246
-417
-3% -$4.22K ﹤0.01% 3985
2018
Q4
$80K Buy
+12,663
New +$80K ﹤0.01% 3925
2015
Q2
Sell
-11,999
Closed -$202K 4757
2015
Q1
$202K Sell
11,999
-8,801
-42% -$148K ﹤0.01% 3892
2014
Q4
$411K Buy
+20,800
New +$411K ﹤0.01% 3495